Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Technology Update

12 Apr 2011 07:00

RNS Number : 7095E
Elektron PLC
12 April 2011
 



Elektron plc

 

Technology Update

 

Elektron Plc ("the Group" or "Elektron") today announces further changes designed to increase its focus on new product development ("NPD").

 

The Group has signed a lease at the Broers Building, a new facility made available by the University of Cambridge for organisations engaged in the field of commercial research and development at its 165 acre West Cambridge site. The facility will become Elektron's Technology Centre from which all NPD activity will be undertaken and managed. Elektron expects to benefit from the deep pool of engineering talent that is located within the Cambridge area - the second largest venture capital market in the world, with over 1000 high tech companies located within the vicinity.

 

In addition to the above, Elektron intends to move its headquarters to Cambridge and as a result its Romford office will be closed at the end of 2011 when the lease expires. A further announcement will be made when this move is complete.

 

The Board is pleased to note some recent successes enjoyed by its technology based brands:

 

*Carnation Designs has secured a £1.2 million contract to supply its genisys electronic management systems for vehicles being supplied for prison escort and custody services into the Ministry of Justice. This system includes full power management tools, bespoke keypads and plug and play vehicle harnesses.

 

*Queensgate Instruments Ltd has led a successful application to the Technology Strategy Board in a recent competition for funding titled "Technology Inspired Collaborative Research and Development". Queensgate has been awarded £182,000 to support its development of high resolution, low noise floor nano-positioning systems. This success clearly illustrates the importance of nano-positioning technology for the future of UK and global high technology manufacturing and the funding will enable Queensgate to ensure its position as a key innovator in the marketplace.

 

*Bulgin continues to meet the required milestones in the development of a new range of connectors that will quadruple its addressable market to $1.3billion.

 

John Wilson, CEO, said "Elektron is very fortunate to have such a diversity of technologies. The opportunities now facing our Group are immense. The centralisation of our Group Technology function underpins our commitment to providing our customers with innovative solutions."

 

Note:

The Technology Strategy Board is a business-led government body which works to create economic growth by ensuring that the UK is a global leader in innovation. Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org.

 

For further information:

 

Elektron PLC

Tel. +44 (0) 1708 336 300

Keith Daley - Chairman

finnCap

Tel. +44 (0)20 7600 1658

Ed Frisby/ Rose Herbert - Corporate Finance

Simon Starr - Corporate Broking

Threadneedle Communications

Tel. +44 (0)20 7653 9850

Josh Royston

Hilary Millar

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASLFFSXFEFF
Date   Source Headline
3rd Jun 20269:53 amRNSForm 8.5 (EPT/RI)
2nd Jun 20269:57 amRNSForm 8.5 (EPT/RI)
1st Jun 202611:33 amRNSForm 8.5 (EPT/RI)
1st Jun 20267:00 amRNSUpdate: Formal Sale Process
29th May 202610:37 amRNSForm 8.5 (EPT/RI)
27th May 20269:50 amRNSForm 8.5 (EPT/RI) - Checkit PLC
26th May 202610:52 amRNSForm 8.5 (EPT/RI)
22nd May 20262:37 pmRNSResult of AGM
22nd May 202610:49 amRNSForm 8.5 (EPT/RI)
22nd May 20267:00 amRNSAGM Update: Formal Sale Process
21st May 202610:18 amRNSForm 8.5 (EPT/RI) - Checkit PLC
20th May 20262:40 pmRNSForm 8.5 (EPT/RI)
20th May 20262:32 pmEQSForm 8.3 - Checkit PLC
19th May 202611:59 amRNSForm 8.5 (EPT/RI) - Checkit PLC
18th May 202611:04 amRNSForm 8.5 (EPT/RI)
15th May 20269:07 amRNSForm 8.5 (EPT/RI)
14th May 20262:28 pmRNSForm 8.5 (EPT/RI)
12th May 202610:10 amRNSForm 8.5 (EPT/RI)
11th May 20261:39 pmRNSForm 8.5 (EPT/RI)
8th May 20269:54 amRNSForm 8.5 (EPT/RI)
7th May 202611:09 amRNSForm 8.5 (EPT/RI)
6th May 20269:50 amRNSForm 8.5 (EPT/RI)
5th May 202610:06 amRNSForm 8.5 (EPT/RI)
1st May 202611:57 amRNSForm 8.5 (EPT/RI) - Checkit PLC
28th Apr 202610:00 amRNSForm 8.5 (EPT/RI)
27th Apr 202611:31 amRNSPosting of Annual Report and Notice of AGM
27th Apr 202610:26 amRNSForm 8.5 (EPT/RI) - Checkit PL
24th Apr 202610:46 amRNSForm 8.5 (EPT/RI)
23rd Apr 202611:33 amEQSForm 8.3 -Checkit PLC
23rd Apr 202611:17 amRNSForm 8.5 (EPT/RI) - Checkit PLC
22nd Apr 202610:10 amRNSForm 8.5 (EPT/RI)
21st Apr 202610:23 amRNSForm 8.5 (EPT/RI)
21st Apr 20267:00 amRNSFinal Results
20th Apr 202610:34 amRNSForm 8.5 (EPT/RI) - Replacement
20th Apr 20269:53 amRNSForm 8.5 (EPT/RI)
17th Apr 202610:37 amEQSForm 8.3 - Checkit PLC
17th Apr 20269:37 amRNSForm 8.5 (EPT/RI)
16th Apr 202610:48 amRNSForm 8.3 - Checkit PLC
16th Apr 20269:57 amRNSForm 8.5 (EPT/RI)
15th Apr 20269:31 amRNSForm 8.5 (EPT/RI)
14th Apr 20262:00 pmEQSForm 8.3 - Checkit plc
14th Apr 202610:03 amRNSForm 8.5 (EPT/RI)
13th Apr 20262:29 pmEQSForm 8.3 - Checkit plc
13th Apr 202611:46 amRNSForm 8.5 (EPT/RI)
10th Apr 202612:47 pmEQSForm 8.3 - Checkit PLC
10th Apr 202611:58 amRNSForm 8.5 (EPT/RI)
9th Apr 202611:34 amRNSForm 8.5 (EPT/RI)
9th Apr 20268:04 amEQSForm 8.3 - Checkit PLC
8th Apr 202612:51 pmRNSForm 8.3 - Checkit PLC
8th Apr 202612:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.